/PRNewswire/ - Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person s risk.
TORONTO, Aug. 31, 2022 /PRNewswire/ Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C
TORONTO, Aug. 10, 2022 /PRNewswire/ Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of Type
/PRNewswire/ - Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person s risk.
TORONTO, Aug. 10, 2022 /PRNewswire/ Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk ofType 2 Diabetes, Hypercholesterolemia, Hypertriglyceridemia and Hypertension. This is important because it will someday allow people to screen themselves using any device with a video camera such as a smartphone or tablet. Researchers at the company trained their machine learning based models on the facial blood flow patterns of tens of thousands of subjects who had been diagnosed with the above conditions. All of the models predicted with a minimum AUC > 0.80. Compare this with the classic Framingham model for predicting cardiovascular disease which had an AUC in the range of 0.70. "This technology is a disruptive tool for population health," said Dr. Keith Thompson, Primary Care Physician of over 30 years,and Chief Medical Officer at NuraLogix, "We live in an Era where 1/2 of the g